This crucial finding indicates that ESRP1 can not only inhibit the EMT by regulating alternative splicing, but can also inhibit the proliferation of tumor cells by regulating mRNA stability in tumor progression, suggesting that ESRP1 may be an important candidate target for future cancer treatment efforts. Here, ESRP1 is linked to cancer.